IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Evaluating the prevalence of Multiple Drug Resistant Tuberculosis (MDR-TB) and Extensive Drug Resistant Tuberculosis (XDR-TB) and the factors affecting them (A Review)

Author: SADEGH DEHGHANMEHR, SAEIDEH VARASTEH, ELHAM ALLAHYARI, NASRIN MIRSHEKARI, PARSA MOHAMMADI, ZAHRA MIRSARGAZI
Abstract: Drug-resistant tuberculosis is developing in Iran and the world and now the emergence of resistant strains to most drugs (MDR-TB and XDR-Extensive Drug Resistant) is a serious threat in the control and treatment of Tuberculosis. We searched for studies in PubMed and Embase and Web of Science and ISI and Embase From Keywords Tuberculosis, Drug Resistant TB, Multiple Drug Resistant AND Extensive Drug Resistant. . Of the 1452 abstracts found initially, The researchers chose 39 articles that included entry criteria and most relevance to the subject. Regarding the spread and prevalence of MDR-TB and XDR-TB and the emergence of new drug-resistant forms such as Pre-XDR-TB and TDR-TB, and the problems that arise in the treatment of these advanced forms of tuberculosis, including the inability of all patients to take medications and increased drug resistance, preventing the development of drug-resistant Mycobacterium tuberculosis strains should be prioritized.
Keyword: Multiple Drug Resistant Tuberculosis (MDR-TB), Extensive Drug Resistant Tuberculosis (XDR-TB), Systematic Review
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus